Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FURAZOLIDONE Cause Benign prostatic hyperplasia? 21 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Benign prostatic hyperplasia have been filed in association with FURAZOLIDONE. This represents 7.1% of all adverse event reports for FURAZOLIDONE.

21
Reports of Benign prostatic hyperplasia with FURAZOLIDONE
7.1%
of all FURAZOLIDONE reports
21
Deaths
20
Hospitalizations

How Dangerous Is Benign prostatic hyperplasia From FURAZOLIDONE?

Of the 21 reports, 21 (100.0%) resulted in death, 20 (95.2%) required hospitalization, and 20 (95.2%) were considered life-threatening.

Is Benign prostatic hyperplasia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FURAZOLIDONE. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does FURAZOLIDONE Cause?

Condition aggravated (145) Hyponatraemia (144) Abdominal distension (143) Multiple organ dysfunction syndrome (141) General physical health deterioration (140) Stress (140) Abdominal pain (139) Appendicitis (139) Ascites (139) Sepsis (139)

What Other Drugs Cause Benign prostatic hyperplasia?

TADALAFIL (596) TAMSULOSIN (304) FINASTERIDE (266) PANTOPRAZOLE (261) PREDNISONE (257) ALBUTEROL (254) ASPIRIN (243) TIOTROPIUM (235) RAMIPRIL (193) AMLODIPINE (179)

Which FURAZOLIDONE Alternatives Have Lower Benign prostatic hyperplasia Risk?

FURAZOLIDONE vs FUROSEMIDE FURAZOLIDONE vs FUROSEMIDE\SPIRONOLACTONE FURAZOLIDONE vs FUSIDATE FURAZOLIDONE vs FUSIDIC ACID FURAZOLIDONE vs FUTIBATINIB

Related Pages

FURAZOLIDONE Full Profile All Benign prostatic hyperplasia Reports All Drugs Causing Benign prostatic hyperplasia FURAZOLIDONE Demographics